Table 3.

Total all-cause healthcare costs and MM-related healthcare costs incurred following the index date^a

	All patients N = 85	Patients < 65 years of age (Commercially insured) N = 76
Follow-up duration in months, mean	20.9	21.1
All-cause total healthcare costs per patient, meanb	$722,992	$749,503
All-cause total healthcare costs PPPM, meanb	$34,578	$35,473
MM-related healthcare costs per patient, meanb
Inpatient cost	$89,668	$97,260
Emergency room cost	$1,007	$918
Outpatient cost	$105,076	$113,548
MM drug cost	$415,475	$419,288
MM drug infusion cost	$17,405	$18,239
Stem cell transplant cost	$21,123	$23,055
Other costs	$5,770	$5,937
Total costs	$655,524	$678,245

^aIndex date, defined as the initiation date of first LOT post-TCE

^bAverage cost for all patients in the sample; patients may not have incurred a cost in every category

LOT line of therapy, MM: multiple myeloma, PPPM per patient per month, TCE triple class exposure